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We have used mRNA differential display to search for cellular genes whose expression is modulated in SV40-transformed
cells. We identified a gene, the a1 subunit of type XI procollagen (a1(XI)), whose mRNA level is reduced in most F111 rat
cell lines that express either wild-type SV40 T antigen or an amino-terminal fragment of T antigen (T147D). a1(XI) mRNA
expression is also reduced in rat embryo fibroblasts transformed by SV40. This phenomenon is not unique to rat cells,
because a1(XI) mRNA expression is repressed in C3H10T1/2 mouse cells transformed by either T147D or wild-type SV40.
Interestingly, a1(XI) mRNA levels are not reduced in F111 cells that express only the polyomavirus large T antigen, but are
reduced in F111 cells transformed by polyoma virus (which expresses all three polyomavirus T antigens) and in F111 cells
that express the adenovirus E1A proteins. Thus, repression of a1(XI) mRNA expression may be a common feature of
transformation by DNA tumor viruses. q 1996 Academic Press, Inc.
A growing body of evidence suggests that SV40 large that genes whose expression is modulated in T147D
transformants will represent a subset of those whoseT antigen transforms cells in culture and causes tumors
in animals, at least in part, by modulating the expression expression is modulated by wild-type T antigen and that
this subset will be enriched in genes that are importantof cellular genes. Large T antigen can transactivate a
variety of cellular and viral promoters (1, 5, 7–9, 16, 17, for SV40 transformation.
Using DD, we compared the levels of mRNAs found19, 23, 24, 42, 44) and can stimulate expression of or
alter activities of cellular transcription factors (15, 26, 27, in three cell lines: normal F111 cells, F111 cells trans-
formed by wild-type SV40, and F111 cells transformed31). In addition to upregulating mRNA expression, SV40
by mutant T147D. We identified one mRNA that was ex-large T antigen can also repress the expression of cellu-
pressed in the untransformed line, but not in either oflar mRNAs (13, 20, 26, 29, 30, 45, 46).
the transformed lines. During our initial characterizations,To look for cellular genes whose modulated expres-
we called the gene that encodes this differentially ex-sion might be involved in SV40 transformation, we used
pressed mRNA, DD31. We used DD31 cDNA to probea modification (38) of the mRNA differential display tech-
Northern blots of poly(A)/ RNA from normal F111 cellsnique (DD) (22) to compare levels of mRNAs expressed
and a total of 10 SV40-transformed F111 lines that ex-in F111 cells (an established line of Fisher rat fibroblasts)
press either wild-type large and small T antigens, wild-with the levels expressed in F111 cells transformed by
type large T antigen alone or the T147D truncated largewild-type SV40 or by an SV40 mutant, T147D. Although
T protein. Autoradiograms of these blots (Figs. 1a andthis mutant expresses only the amino-terminal 147 amino
1b) reveal an approximately 7-kb mRNA that is muchacids of large T antigen and does not encode small t, it
more abundant in normal F111 cells than in 8 of the 10is still able to induce cellular DNA synthesis in quiescent
transformed lines.fibroblasts (37) and transform precrisis rat embryo fibro-
To test whether the modulated expression of DD31blasts and established rodent cell lines, including mouse
was peculiar to F111 rat cells, we used Northern blottingC3H10T1/2, rat F111, and rat REF52 (33–36). Our ratio-
to examine DD31 expression in C3H10T1/2 mouse cellsnale for using cells transformed by T147D is that the
transformed by either T147D or wild-type SV40. Figuremutant lacks viral replication functions of wild-type large
1c shows that DD31 expression is downregulated in bothT antigen that may also modulate the expression of cellu-
types of transformed mouse cell lines. Next, we usedlar genes, leading to a background of gene activation or
DD31 to probe Northern blots of poly(A)/ RNA from F111repression unrelated to transformation. Thus, we expect
cells that express the adenovirus (Ad5) E1A proteins or
from F111 cells transformed by polyomavirus. Figures 1d
and 1e show that DD31 mRNA is more abundant in nor-1 To whom correspondence should be addressed. Fax: (303) 492-
7744. E-mail: laurens@colorado.edu. mal F111 cells than in cells expressing either the E1A
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FIG. 1. Northern blot analysis of cellular mRNA expression. We subjected 2 mg of poly(A)/ RNA from the indicated cell lines to electrophoresis
on 1% agarose-formaldehyde gels, blotted the RNAs onto Nytran filters (Schleicher and Schuell), and probed the blots with 32P-labeled DD31 cDNA
or, as a loading control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) DNA. (a) Normal F111 rat cells and F111-derived lines that express
either the T147 mutant T antigen (FT147A-C) or SV40 large and small T antigens (FSVA-C). (b) F111 cells and F111-derived lines that express only
the SV40 large T antigen (F883A-D). (c) Normal C3H10T1/2 mouse cells or C3H10T1/2-derived lines that express the T147 T antigen (10T-T147D)
or SV40 large and small T antigens (10T-WT). (d) F111 cells and F111-derived cells that express the Ad5 E1A proteins (FE1A). (e) F111 cells and
polyomavirus-transformed F111 cells (FPy1-4). (f ) F111 cells and F111-derived lines that express only the polyomavirus large T antigen (FPyLT1-4).
(g) Primary rat embryo fibroblasts (RE) and rat embryo fibroblasts transformed by SV40 (RESV). (h) Rat glial (9L) and neuronal (PC12-1) cell lines
and a 9L-derived cell line (3D) that expresses the adenovirus (Ad5) E1 proteins. T147D and T147NS are SV40 mutants that express only the amino-
terminal 147 amino acids of large T antigen and which do not express small t antigen (34). d1883 is an SV40 mutant that expresses a normal large
T antigen, but no small t antigen (32). pMTEBE1A is a plasmid that expresses the adenovirus (Ad5) E1A proteins (48). pY3 (4) and pSVneo (39)
confer resistance to hygromycin and G418, respectively. FT147A-C were derived by transfecting F111 cells with plasmids that express either T147NS
from a modified SV40 promoter (pSRa296) (43) (lines A and C) or T147D from the natural SV40 early promoter (line B), and selecting individual
colonies from soft agar (34). Lines 10T-T147 and 10T-WT were derived from individual foci of C3H10T1/2 cells transfected with, respectively, T147D
or the wild-type SV40 early region, each under the control of the SV40 early promoter (34). FSVA-C were derived from individual agar colonies of
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tectable levels in liver, lung, and heart. Since DD31
mRNA is expressed at high levels in brain tissue, we
used Northern blotting to examine DD31 expression in
rat tumor cell lines with glial (9L) or neuronal (PC12-1)
properties. Figure 1h shows that DD31 mRNA is abun-
dant in the glial line, but not in the neuronal line, and
that DD31 expression is dramatically down-regulated in
a derivative of the 9L line (3D) that expresses the adeno-
virus E1 proteins.
The original DD31 cDNA represents only about 300
bases at the extreme 3 * end of the DD31 mRNA. Because
FIG. 2. Northern blot of poly(A)/ RNA from various rat tissues. We we found no match for this cDNA in Genbank, we used
used DD31 cDNA to probe a commercial tissue blot (Clontech) on a RT-PCR technique (38) to obtain a longer DD31 cDNA.
which 2 mg of poly(A)/ RNA from different tissues is displayed.
When we compared 192 bases at the 5* end of this clone
with sequences in Genbank, we found almost complete
proteins or the polyomavirus T antigens. Thus, expres- identity (190/192) with the published DNA sequence near
sion of DD31 mRNA is reduced in cells that express the the 3 * end of the coding region for the a1 subunit of rat
tumor antigens of three DNA tumor viruses: adenovirus, type XI procollagen (3).
polyomavirus, and SV40. In summary, we have used differential display to iden-
As noted above, DD31 expression is downregulated tify a cellular gene, the a1 subunit of type XI procollagen,
in polyomavirus-transformed F111 cells that express the whose mRNA expression is downregulated in most rat
three polyomavirus tumor antigens: large, middle, and and mouse cells transformed by either wild-type SV40 T
small t. Since the polyomavirus and SV40 large T anti- antigen or T147D, an SV40 mutant that encodes only
gens are able to perform some of the same functions, the amino-terminal 147 amino acids of large T antigen.
we tested whether, like the SV40 large T antigen, the Relative to the levels found in parental cells, a1(XI) mRNA
polyoma large T antigen alone could downregulate DD31 is also less abundant in rat cell lines that express the
expression. The Northern blot in Fig. 1f shows that DD31 adenovirus E1A proteins, in polyomavirus-transformed
expression is not reduced in four F111 derivatives that F111 cells that express all three polyomavirus T antigens,
express only the polyomavirus large T antigen. When and in SV40-transformed rat embryo fibroblasts. Thus,
analyzed by immunoprecipitation, the amount of T anti- repression of a1(XI) mRNA expression may be a common
gen in each of these lines is comparable to that found feature of transformation by DNA tumor viruses. A de-
in polyomavirus transformants. Thus, the SV40 large T creased level of this mRNA is not a general result of
antigen and the polyomavirus large T antigen differ in transformation, however, since the 9L rat gliosarcoma
their abilities to downregulate DD31 mRNA expression. line (Fig. 1h) and the A-204 (47) human rhabdomyosar-
In the experiments described thus far, we examined coma line both express high levels of a1(XI) mRNA.
DD31 expression in established cell lines. However, we We believe these results are of interest for several
also tested whether DD31 expression is downregulated reasons. First, although many cellular mRNAs are upreg-
in primary Fisher rat embryo fibroblasts transformed by ulated by SV40 transformation, only a few examples of
SV40. Figure 1g shows that DD31 mRNA is much less mRNAs repressed in SV40-transformed cells have been
abundant in the transformed than in the untransformed noted, and in each of these publications, only a single
rat embryo fibroblasts. To test whether the expression SV40-transformed line was tested (13, 20, 29, 30, 45).
of DD31 mRNA is tissue specific, we used DD31 to probe Thus, in addition to adding another entry to the short list
a Northern blot of poly(A)/ RNA isolated from various of genes whose expression is downregulated in SV40-
normal rat tissues. Figure 2 shows that DD31 mRNA is transformed cells, our report is the first study in which
most abundant in brain; relatively abundant in kidney, decreased mRNA abundance has been documented in
a large panel of transformed lines.muscle, testis, and spleen; and present at low or unde-
F111 cells transfected with the SV40 early region under the control of the SV40 promoter (33). F883A was obtained from an agar colony of F111
cells transfected with the dl883 early region under the control of a retroviral LTR promoter (35). F883B-D each originated from a G418R colony that
resulted from independent cotransfections of F111 cells with pSVneo and dl883. Cell lines FPyLT1-4 were expanded from drug resistant colonies
that arose from independent cotransfections of F111 cells with a plasmid that contains the polyomavirus large T antigen cDNA (18) under control
of the SRa296 promoter together with either pY3 (FPyLT1) or pSVneo (FPyLT2-4). FE1A was obtained from a G418R colony of F111 cells cotransfected
with pSVneo and pMTEBE1A. FPy1 (called FPyLpA5 in 11) and FPy2-4 (10) were derived from agar colonies of F111 cells infected with polyomavirus.
RESV was derived from an agar colony of primary rat embryo fibroblasts that were transfected with a plasmid containing the early region of SV40
under the control of the SV40 promoter (35). PC12-1 is a rat pheochromocytoma cell line with neuronal properties (14). Line 3D was derived from
the rat gliosarcoma line, 9L (12), by transfecting with a plasmid that expresses the E1 proteins of adenovirus type 5 (T. Walker and J. Cook,
unpublished).
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TABLE 1 similar cell lines in which a1(XI) mRNA levels are re-
duced.Growth in Soft Agar
Given the nature of the a1(XI) collagen protein, this
Cell T Agar a1(XI) failure of an in vitro transformation assay to detect a
line Antigena growthb Suppression difference in phenotype between lines expressing differ-
ent levels of a1(XI) mRNA is not surprising. The extracel-
F111 NONE 0 NO
lular matrix (ECM) consists in part of collagen moleculesF883A T / YES
that form a structural lattice and proteoglycans whichF883B T / NO
F883C T / YES comprise the gelatinous substance in which the lattice
F883D T / YES is embedded. Because these materials are secreted by
FSVA T, t /// NO the cells that inhabit the matrix, the cells themselves play
FSVB T, t /// YES
a large role in determining the environment in which theyFSVC T, t // YES
reside, with cells in different tissues secreting differentFT147A T147 // YES
FT147B T147 /// YES types of collagen. Although Type XI collagen is a rela-
FT147C T147 /// YES tively minor component of the ECM, it is believed to play
an important role in controlling the size of collagen fibrilsa SV40 T antigens: large T (T), small t (t), amino-terminal fragment of
in some tissues (25). Mice homozygous for the autosomallarge T (T147).
recessive chondrodysplasia (cho) mutation are defectiveb Indicates relative frequency of large colonies.
for the production of a1(XI) (21). In these mice, the carti-
lage matrix lacks cohesiveness, and glycosaminoglycan
can be extracted more easily than from the ECM of nor-In addition, our results suggest that reduced levels of
a1(XI) mRNA may play an important role in SV40 transfor- mal mice (41). Thus, an ECM which is deficient in a1(XI)
is looser than normal, suggesting that the downregula-mation. The amino-terminal 147 amino acids of T antigen
are sufficient to repress a1(XI) mRNA levels, and this tion of a1(XI) mRNA expression by SV40 may be one way
that SV40 alters the composition of the ECM to createregion of T antigen is also sufficient to immortalize and
transform precrisis rat embryo fibroblasts, to transform an extracellular environment more conducive to tumori-
genesis. Experiments with animal models are now inestablished rodent cell lines, and to cause tumors in
nude and transgenic mice (2, 6, 28, 33–36, 40). Thus, a progress to test this hypothesis.
region of T antigen that is sufficient for transformation is
also sufficient for a1(XI) repression. In addition, we ob- ACKNOWLEDGMENTS
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